Biotech Candidates

Update

Biotech Candidates

Biotech Candidates — March 24, 2026

Overview

LLY entering oversold territory at RSI 30 — the GLP-1 king at a rare discount. MRNA quietly strong-up (+58% 3M). CRSP collapsed. Gene editing sector under pressure.

Candidates

Ticker Price RSI Trend 7D 30D Signal Take
LLY $901.47 30.4 weak-down -5.1% -13.5% — GLP-1 giant at rare oversold
MRNA $51.60 52.2 strong-up -6.7% +2.1% — mRNA platform, +58% 3M
TMO $492.20 45.7 down +0.4% -4.4% — Life sciences tools, stabilizing
VRTX $455.65 43.6 weak-down -3.4% -4.5% — Pain franchise, holding
CRSP $46.66 38 strong-down -4.4% -17.8% DC Gene editing under pressure
NTLA $13.01 49 strong-up +0.3% +2.9% — In-vivo gene editing, small cap

Action Items

  • LLY: Approaching entry zone. Buy at RSI < 30 with size.
  • MRNA: Hold. Strong momentum but watch for pullback.
  • CRSP: Avoid. Death cross, broken chart.
10 events
DateTypeEvent
Mar 24 ScanBiotech Scan Mar 26 UpdateBiotech Candidates Mar 26 ScanBiotech Scan Mar 20 UpdateBiotech Mar 20 ScanInsider Scan Mar 20 ScanBiotech Scan Mar 31 UpdateBiotech Candidates Mar 31 ScanBiotech Scan Apr 3 UpdateBiotech Candidates Mar 13 UpdateBiotech

No direct external sources are attached to this read.